Trilogy Capital’s ASA Gold and Precious Metals ASA Stock Holding History

Trilogy Capital’s Portfolio ASA Stock Details ASA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,000	Closed	-$9K	–	162
2018 Q3	$9K	Hold	1,000	–	–	﹤0.01%	332
2018 Q2	$10K	Buy	+1,000	New	+$10.5K	﹤0.01%	297

Other funds holding ASA

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UCI

Uncommon Cents Investing Janesville, Wisconsin $431M AUM 32.59% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

PVWM

Point View Wealth Management Summit, New Jersey $246M AUM 10.77% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

ADBIC

A.D. Beadell Investment Counsel Mequon, Wisconsin $156M AUM 29.03% 1-Year Est. Return

Trilogy Capital's ASA Position: Q4 2018 in Review

Trilogy Capital sold out of ASA Gold and Precious Metals (ASA) in Q4 2018, closing a stake of 1,000 shares — an estimated $9K sold.

Trilogy Capital first reported a position in ASA in Q2 2018 and held it in 2 quarters. The position peaked at $10K in Q2 2018. 52 funds tracked by Wall St. Rank hold ASA as of Q4 2018.

Trilogy Capital reported no remaining ASA Gold and Precious Metals position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 1,000 ASA Gold and Precious Metals shares in Q4 2018, an estimated $9K.
Trilogy Capital first reported a position in ASA Gold and Precious Metals in Q2 2018 and held it in 2 quarters.
Trilogy Capital's ASA Gold and Precious Metals position peaked at $10K in Q2 2018.
52 funds tracked by Wall St. Rank held ASA Gold and Precious Metals as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.